康希诺生物

Information Disclosure

Home >Investor Relations >Information Disclosure

H Share

VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR INHALED TB BOOSTER IN INDONESIA
Form of Proxy for use at the 2025 Second Extraordinary General Meeting to be held on Thursday, November 27, 2025
NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
2025 SECOND EGM CIRCULAR
INSIDE INFORMATION - USING RESERVES TO OFFSET LOSSES
Monthly Return of Equity Issuer on Movements in Securities
TERMS OF REFERENCE FOR THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF THE BOARD
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD
(1) PROPOSED CANCELLATION OF THE BOARD OF SUPERVISORS AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RULES OF PROCEDURES; (2) PROPOSED AMENDMENTS TO THE CORPORATE GOVERNANCE RULES; (3) RESIGNATION OF DIRECTORS AND (4) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS

1 2 3 4 5 6 50